CR20190028A - HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS - Google Patents

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Info

Publication number
CR20190028A
CR20190028A CR20190028A CR20190028A CR20190028A CR 20190028 A CR20190028 A CR 20190028A CR 20190028 A CR20190028 A CR 20190028A CR 20190028 A CR20190028 A CR 20190028A CR 20190028 A CR20190028 A CR 20190028A
Authority
CR
Costa Rica
Prior art keywords
immunomodulators
compounds
heterocyclic compounds
cancers
infections
Prior art date
Application number
CR20190028A
Other languages
Spanish (es)
Inventor
Wenqing; Yao
Liangxing Wu
Kaijiong Xiao
Fenglei Zhang
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Priority claimed from PCT/US2017/038120 external-priority patent/WO2017222976A1/en
Publication of CR20190028A publication Critical patent/CR20190028A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describen compuestos de Fórmula (I), métodos para el uso de los compuestos como inmunomoduladores y composiciones farmacéuticas que comprenden dichos compuestos. Los compuestos son útiles para el tratamiento, prevención o mejora de enfermedades o trastornos tales como cánceres o infecciones.Compounds of Formula (I), methods for the use of the compounds as immunomodulators and pharmaceutical compositions comprising said compounds are described. The compounds are useful for the treatment, prevention or improvement of diseases or disorders such as cancers or infections.

CR20190028A 2016-06-19 2017-06-19 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS CR20190028A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662296353P 2016-06-19 2016-06-19
US201662352485P 2016-06-20 2016-06-20
PCT/US2017/038120 WO2017222976A1 (en) 2016-06-20 2017-06-19 Heterocyclic compounds as immunomodulators

Publications (1)

Publication Number Publication Date
CR20190028A true CR20190028A (en) 2019-05-15

Family

ID=67060167

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20190028A CR20190028A (en) 2016-06-19 2017-06-19 HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Country Status (1)

Country Link
CR (1) CR20190028A (en)

Similar Documents

Publication Publication Date Title
CO2019000386A2 (en) Heterocyclic compounds as immunomodulators
CO2019007863A2 (en) Benzooxazole derivatives as immunomodulators
CO2018007528A2 (en) Heterocyclic compounds as immunomodulators
ECSP20079887A (en) TETRAHYDRO-IMIDAZO [4,5-C] PYRIDINE DERIVATIVES AS PD-L1 IMMUNOMODULATORS
ECSP20069418A (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
CL2017002494A1 (en) Indolamine-2, 3- dioxygenase inhibitors for cancer treatment
CL2018000542A1 (en) New phenoxymethyl derivatives.
CU20160162A7 (en) DERIVATIVES OF PIRROLIDINA-2,5-DIONA, TO USE AS IDO1 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NI201600144A (en) QUINOXALINE DERIVATIVES USEFUL AS MODULATORS OF FGFR KINASE
BR112017003054A2 (en) aminopyrimidinyl compounds as jak inhibitors
BR112016023558A2 (en) compounds useful as immunomodulators
CL2015002767A1 (en) Therapeutic compounds and compositions
ECSP19035077A (en) MAGL INHIBITORS
ECSP19035377A (en) MAGL INHIBITORS
CL2016002091A1 (en) Triazine compound and its use for medicinal purposes
ECSP17074645A (en) AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS
CO2017007325A2 (en) 2,4-substituted diamino-quinoline as new anti-cancer agents
CO2017001226A2 (en) 6-alkynyl-pyridine derivatives as smac mimetics
CL2018001085A1 (en) Indolin-2-one derivatives
UY36758A (en) INHIBITORS OF THE ZESTE 2 HOMOLOGIST POTENTIATOR
CL2020001062A1 (en) Bicyclic sulfones and sulfoxides and methods of using them.
UY36217A (en) PIRIDONA SUBSTITUTE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE.
CL2015003431A1 (en) Pyridone derivatives for the treatment of viral infections and additional diseases
UY36732A (en) PIRIDIN PIRAZINONAS NOVEDOSAS AS BROMODOMINIUM INHIBITORS OF THE BET FAMILY
CO2021014351A2 (en) Quinoline derivatives and their use for cancer treatment